GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
Series GSE120919 Query DataSets for GSE120919
Status Public on Mar 28, 2020
Title Genome-wide survey of adjacent gene rearrangements in breast cancer identifies triple-negative specific BCL2L14-ETV6 fusions
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Summary Purpose: We investigated the function of overexpressed BCL2L14-ETV6 fusion variants in triple-negative breast cancer using high-throughput mRNA sequencing (RNA-Seq) analysis in BT20 human basal-like breast cancer cell line.
Methods: The BCL2L14-ETV6 fusion variants or wildtype ETV6 cDNA containing the full-length ORFs were subcloned into the lentiviral pLenti7.3 vector, and later transduced into the BT20 cell line. BT20 cells were cultured in EMEM (ATCC) with 10 % fetal bovine serum (Hyclone). Total RNA was extracted from cells in individual confluent 10 cm dish, using the standard procedure of Qiagen RNeasy kit. The NovaSeq 6000 library for DNA sequencing was prepared using TruSeq Stranded mRNA Library Prep Kit (Illumina) following the protocol provided by the manufacturer. The final libraries were normalized by quantification with LightCycler 480 II (Roche Applied Science, Indianapolis, IN, USA) and qualification with Bioanalyzer (Agilent, Palo Alto, CA, USA). The final loading concentration was adjusted to 10 pM following the NovaSeq 6000 loading protocol. The NovaSeq 6000 S2 Reagent Kit (Illumina) was used for paired-end reads (2×150 bp) sequencing reactions. Sequencing data was given as raw data with a Phred Q30 score of 80 or better.
Results: Confirming the overexpression of BCL2L14-ETV6 fusion variants, the reads that match to partial of BCL2L14 and ETV6 mRNA transcripts were 32~256 fold higher in the stable BT20 cell lines expressing BCL2L14-ETV6 fusion, compared to the cells the express the vector control. We found some key genes in cell migration and invasion are up-regulated in these stable BT20 cells compared with the cells the express the vector control and the wildtype ETV6.
Conclusions: BCL2L14-ETV6 fusions endow enhanced cell migration and invasion in breast cancer.
Overall design We generated the stable BT20 cell models by transduction of the lentivirus containing either the pLenti7.3 vector control expresssing the lacZ gene, wildtype ETV6 cDNA, or three BCL2L14-ETV6 fusion variants E2E3 (BCL2L14-Exon2_ETV6-Exon3), E4E3 (BCL2L14-Exon4_ETV6-Exon3) and E4E2 (BCL2L14-Exon4_ETV6-Exon2). Each group was triplicated in the RNAseq expriments.
Contributor(s) Hu Y, Lee S, Loo S, Wang X
Citation(s) 32321829
NIH grant(s)
Grant ID Grant title Affiliation Name
Submission date Oct 08, 2018
Last update date Aug 25, 2020
Contact name Xiaosong Wang
Organization name University of Pittsburgh
Department Pathology
Lab Cagenome
Street address 5150 Centre Ave
City Pittsburgh
State/province Pennsylvania
ZIP/Postal code 15232
Country USA
Platforms (1)
GPL24676 Illumina NovaSeq 6000 (Homo sapiens)
Samples (15)
GSM3420769 YH6_1_BT20_Control_rep1
GSM3420770 YH6_2_BT20_Control_rep2
GSM3420771 YH6_3_BT20_Control_rep3
BioProject PRJNA495013
SRA SRP164390

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE120919_RAW.tar 8.3 Mb (http)(custom) TAR (of TXT)
GSE120919_normalized_TPMlog2_values.xlsx 6.3 Mb (ftp)(http) XLSX
SRA Run SelectorHelp
Raw data are available in SRA
Processed data provided as supplementary file
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap